|
|
|
|
|
|
by Cu3PO42
1980 days ago
|
|
|
They were working on applying mRNA technology to other diseases, including (and in particular) cancer, well before the pandemic. While it is true that they have received significant funding this year, they had a $7.6B market cap on Dec 31, 2019 and were already conducting several clinical studies for mRNA-based medicine [1]. [1] https://web.archive.org/web/20200128054759/https://biontech.... |
|
|